How to buy Aziyo Biologics stock - 05 March

Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Aziyo Biologics stock

Own Aziyo Biologics stock in just a few minutes.

Updated . What changed?

Fact checked

Aziyo Biologics, Inc is a medical devices business based in the US. Aziyo Biologics shares (AZYO) are listed on the NASDAQ and all prices are listed in US Dollars. Aziyo Biologics employs 156 staff and has a trailing 12-month revenue of around USD$42.3 million.

How to buy shares in Aziyo Biologics

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for Aziyo Biologics. Find the stock by name or ticker symbol: AZYO. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Aziyo Biologics reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. Weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Aziyo Biologics, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of Aziyo Biologics. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Aziyo Biologics share price

Use our graph to track the performance of AZYO stocks over time.

Aziyo Biologics shares at a glance

Information last updated 2021-03-03.
52-week rangeUSD$10.55 - USD$18
50-day moving average USD$15.5521
200-day moving average USD$13.6096
Wall St. target priceUSD$20
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) N/A

Buy Aziyo Biologics shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee Signup bonus
Robinhood
$0
Stocks, Options, ETFs, Gold/Commodities
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Webull
$0
Stocks, Options, ETFs
$0
0%
Get two free stock valued between $2.50 and $250
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
TradeStation
$0
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$50
Deposit qualifying assets of $5,000+
A platform built for all kinds of traders and all styles of trading
Tastyworks
$0
Stocks, Options, Cryptocurrency
Stocks & ETFs: $1/contract to open, $0 to close, $10 max/leg
Futures: $2.50/contract to open, $0 to close
0%
Get 100 shares of stock (worth $1 to $6 a share)
Open and fund a new cash or margin account with $2,000+
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
Interactive Brokers
$0
Stocks, Bonds, Options
$0 + $0.65/contract, $1 minimum
0%
N/A
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Aziyo Biologics stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Aziyo Biologics financials

Revenue TTM USD$42.3 million
Gross profit TTM USD$19.8 million
Return on assets TTM 0%
Return on equity TTM 0%
Profit margin -45.54%
Book value N/A
Market capitalisation USD$155.9 million

TTM: trailing 12 months

Shorting Aziyo Biologics shares

There are currently 153,475 Aziyo Biologics shares held short by investors – that's known as Aziyo Biologics's "short interest". This figure is 2% down from 156,647 last month.

There are a few different ways that this level of interest in shorting Aziyo Biologics shares can be evaluated.

Aziyo Biologics's "short interest ratio" (SIR)

Aziyo Biologics's "short interest ratio" (SIR) is the quantity of Aziyo Biologics shares currently shorted divided by the average quantity of Aziyo Biologics shares traded daily (recently around 13185.137457045). Aziyo Biologics's SIR currently stands at 11.64. In other words for every 100,000 Aziyo Biologics shares traded daily on the market, roughly 11640 shares are currently held short.

To gain some more context, you can compare Aziyo Biologics's short interest ratio against those of similar companies.

However Aziyo Biologics's short interest can also be evaluated against the total number of Aziyo Biologics shares, or, against the total number of tradable Aziyo Biologics shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Aziyo Biologics's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 Aziyo Biologics shares in existence, roughly 20 shares are currently held short) or 0.0514% of the tradable shares (for every 100,000 tradable Aziyo Biologics shares, roughly 51 shares are currently held short).

A SIR above 10% would generally be considered pretty high, pointing to a potentially pessimistic outlook for the share price and a discouraging interest in betting against Aziyo Biologics.

Find out more about how you can short Aziyo Biologics stock.

Aziyo Biologics share dividends

We're not expecting Aziyo Biologics to pay a dividend over the next 12 months.

Aziyo Biologics overview

Aziyo Biologics, Inc., a regenerative medicine company, focuses on the development of regenerative medical products to address the implantable electronic device/cardiovascular, orthopedic/spinal repair, and soft tissue reconstruction markets. It offers CanGaroo, a biological envelope that remodels into vascularized tissue for the long-term pocket protection of certain cardiac and neurostimulator implantable electronic devices; and ProxiCor, Tyke, and VasCure, which are a portfolio of extracellular matrices that retain the natural composition of collagen, growth factors, and proteins for use in vascular and cardiac repair, and pericardial closure. The company also provides FiberCel, ViBone, and OsterGro V that are viable matrices designed to protect and preserve native bone cells; and SimpliDerm, a pre-hydrated human cellular dermal matrix designed to meet a range of surgical needs. In addition, it offers contract manufacturing services for various products to corporate customers. The company sells its products to hospitals and other healthcare facilities through its direct sales force, commercial partners, and independent sales agents. Aziyo Biologics, Inc. was founded in 2015 and is headquartered in Silver Spring, Maryland. It has additional offices in Roswell, Georgia; and Richmond, California

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site